Airway inflammation in chronic obstructive pulmonary disease

Current Opinion in Pulmonary Medicine

Volumn 16, Issue 2, 2010, Pages 89-96

  Górska, Katarzyna ^a   Maskey Warzȩchowska, Marta ^a   Krenke, Rafał ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Airways; Chronic obstructive pulmonary disease; Cytokines; Inflammation; Inflammatory cells

Indexed keywords

CYTOKINE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE COURSE; EOSINOPHIL; HUMAN; INFLAMMATORY CELL; MACROPHAGE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; RESPIRATORY TRACT INFLAMMATION; REVIEW;

CYTOKINES; EOSINOPHILS; HUMANS; MACROPHAGES, ALVEOLAR; NEUTROPHILS; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 76449099320     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3283341ba0     Document Type: Review

References (60)

1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO workshop report 2008 update. www.goldcopd.org.
2. Thorleifsson SJ, Margretardottir OB, Gudmundsson G, et al. Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland. Respir Med 2009; 103:1548-1553.
3. Louhelainen N, Rytilä P, Haahtela T, et al. Persistence of oxidant and protease burden in the airways after smoking cessation. BMC Pulm Med 2009; 9: 25-33.
4. Hansel TT, Barnes PJ. New drugs for exacerbations of chronic obstructive pulmonary disease. Lancet 2009; 374:744-755.
5. Hens G, Vanaudenaerde BM, Bullens DMA, et al. Sinonasal pathology in nonallergic asthma and COPD: 'united airway disease' beyond the scope of allergy. Allergy 2008; 63:261-267.
6. Rutgers SR, Timens W, Kaufmann HF, et al. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J 2000; 15:109-115.
7. Rovina N, Dima E, Gerassimou C, et al. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease. Respir Med 2009; 103:1056-1062.
8. Corhay JL, Henket M, Nguyen D, et al. Leukotriene B4 contributes to exhaled breath condensate and sputum neutrophil chemotaxis in COPD. Chest 2009; 136:1047-1054.
9. Sarir H, Mortaz E, Karimi K, et al. Cigarette smoke regulates the expression of TLR4 and IL-8 production by human macrophages. J Inflamm 2009; 6:12-19.
10. Profita M, Giorgi RD, Sala A, et al. Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients. Allergy 2005; 60:1361-1369.
11. Bartoli ML, Di Franco A, Vagaggini B, et al. Biological markers in induced sputum of patients with different phenotypes of chronic airway obstruction. Respiration 2009; 77:265-272.
12. Brown V, Elborn JS, Bradley J, et al. Dysregulated apoptosis and NFkappaB expression in COPD subjects. Respir Res 2009; 10:24-35.
13. Gorska K, Krenke R, Domagala-Kulawik J, et al. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study. J Physiol Pharmacol 2008; 59 (Suppl 6): 271-283.
14. Tsoumakidou M, Koutsopoulos AV, Tzanakis N, et al. Decreased small airway and alveolar CD83+ dendritic cells in COPD. Chest 2009; 136:726-733.
15. Wallace AM, Sandford AJ, English JC, et al. Matrix metalloproteinase expression by human alveolar macrophages in relation to emphysema. COPD 2008; 5:13-23.
16. Löfdahl MJ, Roos-Engstrand E, Pourazar J, et al. Increased intraepithelial T-cells in stable COPD. Respir Med 2008; 102:1812-1818.
17. Tsuda Y, Noguchi T, Mochizuki H, et al. Patients with mild-to-moderate asthma may develop clinically significant chronic obstructive pulmonary disease. Respirology 2009; 14:529-536.
18. Lams BE, Sousa AR, Rees PJ, et al. Subepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease. Eur Respir J 2000; 15:512-516.
19. Hodge G, Nairn J, Holmes M, et al. Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects. Clin Exp Immunol 2007; 150:22-29.
20. Gadgil A, Duncan SR. Role of T-lymphocytes and pro-inflammatory mediators in the pathogenesis of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2008; 3:531-541.
21. Grumelli S, Corry DB, Song LZ, et al. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 2004; 1:75-83.
22. Barceló B, Pons J, Ferrer JM, et al. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking. Eur Respir J 2008; 31:555-562.
23. Kim V, Kelemen SE, Abuel-Haija M, et al. Small airway mucous metaplasia and inflammation in chronic obstructive pulmonary disease. COPD 2008; 5:329-338.
24. Di Stefano A, Caramori G, Gnemmi I, et al. T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin Exp Immunol 2009; 157:316-324.
25. van der Strate BWA, Postma DS, Brandsma CA, et al. Cigarette smokeinduced emphysema: a role for the B cell? Am J Respir Crit Care Med 2006; 173:751-758.
26. Bafadhel M, Saha S, Siva R, et al. Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD. Respiration 2009; 78:256-262.
27. Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004; 56:515-548.
28. Sarir H, Henricks PAJ, van Houwelingen AH, et al. Cells, mediators and Tolllike receptors in COPD. Eur J Pharmacol 2008; 585:346-353.
29. Yagi O, Aoshiba K, Nagai A. Activation of nuclear factor-kappaB in airway epithelial cells in patients with chronic obstructive pulmonary disease. Respiration 2006; 73:610-616.
30. Kelsen SG, Aksoy MO, Georgy M, et al. Lymphoid follicle cells in chronic obstructive pulmonary disease overexpress the chemokine receptor CXCR3. Am J Respir Crit Care Med 2009; 179:799-805.
31. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:2645-2653.
32. Mortaz E, Kraneveld AD, Smit JJ, et al. Effect of cigarette smoke extract on dendritic cells and their impact on T-cell proliferation. PloS ONE 2009; 4:e4946-e4953.
33. Brandsma CA, Hylkema MN, van der Strate BWA, et al. Heme oxygenase-1 prevents smoke induced B-cell infiltrates: a role for regulatory T cells? Respir Res 2008; 9:17-28.
34. Imaoka H, Hoshino T, Takei S, et al. Interleukin-18 production and pulmonary function in COPD. Eur Respir J 2008; 31:287-297.
35. Mortaz E, Redegeld FA, Sarir H, et al. Cigarette smoke stimulates the production of chemokines in mast cells. J Leukoc Biol 2008; 83:575-580.
36. Barnes PJ. New molecular targets for the treatment of neutrophilic diseases. J Allergy Clin Immunol 2007; 119:1055-1062.
37. Pesci A, Majori M, Cuomo A, et al. Neutrophils infiltrating bronchial epithelium in chronic obstructive pulmonary disease. Respir Med 1998; 92:863-870. (Pubitemid 28360616)
38. Simpson JL, Phipps S, Gibson PG. Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis. Pharmacol Ther 2009; 124:86-95.
39. Hacievliyagil SS, Gunen H, Mutlu LC, et al. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease. Respir Med 2006; 100:846-854.
40. O'Reilly P, Jackson P, Noerager B, et al. N-alpha-PGP and PGP, potential biomarkers and therapeutic targets for COPD. Respir Res 2009; 10:38-45.
41. Renda T, Baraldo S, Pelaia G, et al. Increased activation of p38 MAPK in COPD. Eur Respir J 2008; 31:62-69.
42. Makris D, Vrekoussis T, Izoldi M, et al. Increased apoptosis of neutrophils in induced sputum of COPD patients. Respir Med 2009; 103:1130-1135.
43. Bathoorn E, Liesker JJ, Postma DS, et al. Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation. Int J Chron Obstruct Pulmon Dis 2009; 4:101-109.
44. Tzanakis N, Chrysofakis G, Tsoumakidou M, et al. Induced sputum CD8+ T-lymphocyte subpopulations in chronic obstructive pulmonary disease. Respir Med 2004; 98:57-65.
45. Sapey E, Ahmad A, Bayley D, et al. Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD. J Clin Immunol 2009; 29:508-516.
46. Man SFP, Connett JE, Anthonisen NR, et al. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006; 61:849-853.
47. Chaouat A, Savale L, Chouaid C, et al. Role for interleukin-6 in COPD-related pulmonary hypertension. Chest 2009; 136:678-687.
48. Hoshino T, Kato S,OkaN, et al. Pulmonary inflammation andemphysema: role of the cytokines IL-18 and IL-13. Am J Respir Crit Care Med 2007; 176:49-62.
49. Calabrese F, Baraldo S, Bazzan E, et al. IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 178:894-901.
50. Lowrey GE, Henderson N, Blakey JD, et al. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD. Respir Med 2008; 102:845-851.
51. Chen Y, Chen P, Hanaoka M, et al. Enhanced levels of prostaglandin E2 and matrix metalloproteinase-2 correlate with the severity of airflow limitation in stable COPD. Respirology 2008; 13:1014-1021.
52. Togo S, Holz O, Liu X, et al. Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms. Am J Respir Crit Care Med 2008; 178:248-260.
53. Culpitt SV, Rogers DF, Shah P, et al. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167:24-31.
54. Saha S, Doe C, Mistry V, et al. Granulocyte-macrophage colony-stimulating factor expression in induced sputum and bronchial mucosa in asthma and COPD. Thorax 2009; 64:671-676.
55. Takizawa H, Tanaka M, Takami K, et al. Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 2001; 163:1476-1483.
56. Gorska K, Krenke R, Korczynski P, et al. Eosinophilic airway inflammation in chronic obstructive pulmonary disease and asthma. J Physiol Pharmacol 2008; 59 (Suppl 6):261-270.
57. Snoeck-Stroband JB, Lapperre TS, Gosman MME, et al. Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies. Eur Respir J 2008; 31:70-77.
58. Siva R, Green RH, Brightling CE, et al. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J 2007; 29:906-913.
59. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009; 64:728-735.
60. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in nonsmokers. Lancet 2009; 374:733-743.